Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy

Phase 2

Completed

Conditions: Hepatic Cancer

Interventions: Drug: FLOXURIDINE

First Posted Date: 2008-01-07

Last Posted Date: 2023-04-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 34

Registration Number: NCT00587067

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer

Not Applicable

Completed

Conditions: Ovarian Cancer

Interventions: Other: CA 125 and CT scan

First Posted Date: 2008-01-07

Last Posted Date: 2018-02-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 669

Registration Number: NCT00587093

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Md Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma

Phase 2

Completed

Conditions: Osteosarcoma

Interventions: Drug: Cisplatin
Drug: Doxorubicin
Drug: Methotrexate

First Posted Date: 2008-01-07

Last Posted Date: 2016-01-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT00586846

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)

Completed

Conditions: Cancer

Interventions: Other: Blood Samples

First Posted Date: 2007-12-28

Last Posted Date: 2018-11-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 198

Registration Number: NCT00581958

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Feasibility Study of Cone Beam Imaging for Radiation Therapy Treatment Verification

Not Applicable

Completed

Conditions: Radiation Treatment for Tumors

Interventions: Other: Cone Beam Imaging

First Posted Date: 2007-12-28

Last Posted Date: 2014-02-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 19

Registration Number: NCT00582959

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Recruiting

Conditions: Leukemia
Multiple Myeloma
Renal Cancer
Lymphoma
Colon Cancer

First Posted Date: 2007-12-28

Last Posted Date: 2024-01-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 500

Registration Number: NCT00582621

Locations: 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 3 locations

Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue

Completed

Conditions: Melanoma

First Posted Date: 2007-12-28

Last Posted Date: 2009-09-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 876

Registration Number: NCT00581698

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Genetic Studies in Breast Cancer

Completed

Conditions: Breast Cancer
Ovarian Cancer

First Posted Date: 2007-12-28

Last Posted Date: 2009-07-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 483

Registration Number: NCT00582322

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Adherence to Intensive Surveillance for Hereditary Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2007-12-28

Last Posted Date: 2009-07-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 85

Registration Number: NCT00582803

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Seeking Informed Consent to Phase I Cancer Clinical Trials: Identifying Oncologists'Communication Styles

Completed

Conditions: Cancer

Interventions: Other: Consult visit

First Posted Date: 2007-12-28

Last Posted Date: 2009-05-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 17

Registration Number: NCT00582192

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy